ASML to 2030 still has one of the clearest strategic runways in European technology, but long-term targets should be anchored in official demand and margin signals rather than pure AI enthusiasm.

ASML to 2035 still has a rare long-term strategic franchise, but the long-range stock outlook should be framed with explicit revenue, margin, and valuation assumptions rather than pure enthusiasm.

Eli Lilly still has a credible path to a materially larger business by 2030, but the stock is no longer cheap enough for optimism alone. The central question is whether obesity, diabetes, and pipeline ...

AI can help Airbus through manufacturing efficiency, services revenue and predictive maintenance, but it is not yet a stand-alone reason for a separate stock multiple.

Bullish drivers for Novartis based on current company data, valuation, sector context, and actionable scenarios.

Tencent stock analysis for 2030 with current valuation, AI and WeChat drivers, bull-base-bear scenarios, and investor positioning.

ASML remains one of Europe's strongest AI and semiconductor capex franchises, but the 2027 stock range still depends on order conversion, export-control risk, and valuation discipline.

Walmart in context: what the current price already assumes. Walmart closed at $132.46 on May 14, 2026. Over the last 10 years, adjusted monthly closes ran ...

S&P 500 with valuation, earnings, inflation, scenario probabilities, trigger levels, and institutional data updated for mid-2026.

HSBC Holdings in context: what kind of long-term asset this is now. HSBC's long-term chart already tells an important truth. At 1,317p on May 15, 2026, the ...

AstraZeneca can still rally from $184.96, but the bullish case now depends on execution rather than a rerating story. The clean version of that case is straightforward: guidance holds, launches ...

The decade thesis is that DAX remains Europe's premier industrial and software beta. A decade from now, the most important question is whether Germany emer ...